CD8A and neoplasm: Previous studies in the B16‐cOVA model have shown that CD8+ T cells responding to Ag within the context of TILN proliferate but fail to acquire effector function, whereas those responding within TFLN to cross‐presented Ag from recently injected tumor cells differentiate into IFNγ‐secreting effectors [14, 17].